Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy

Scandinavian Cardiovascular Journal

Volumn 45, Issue 3, 2011, Pages 153-160

  Jensen, Morten Kvistholm ^a   Havndrup, Ole ^a   Hassager, Christian ^a   Helqvist, Steffen ^a   Kelbæk, Henning ^a   Jørgensen, Erik ^a   Køber, Lars ^a   Bundgaard, Henning ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Hypertrophic cardiomyopathy; implantable cardioverter defi brillator; percutaneous tranluminal septal ablation; sudden cardiac death; survival

Indexed keywords

ABLATION THERAPY; ADULT; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CATHETER ABLATION; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79957467429     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2011.565793     Document Type: Article

References (20)

1. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic cardiomyopathy is predomi-nantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232-9. (Pubitemid 44789498)
2. Andersen PS, Havndrup O, Hougs L, Sorensen KM, Jensen M, Larsen LA, et al. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encod-ing genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum Mutat. 2009;30:363-70.
3. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42:1687-713. (Pubitemid 37383745)
4. Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, et al. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopa-thy (TASH): A 10 year experience. Clin Res Cardiol. 2008;97:234-43. (Pubitemid 351464524)
5. Baggish AL, Smith RN, Palacios I, Vlahakes GJ, Yoerger DM, Picard MH, et al. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy Heart. 2006;92: 1773-8. (Pubitemid 44851322)
6. Cuoco FA, Spencer WH, III, Fernandes VL, Nielsen CD, Nagueh S, Sturdivant JL, et al. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy J Am Coll Cardiol. 2008;52:1718-23.
7. Elliott PM, Gimeno JR, Tome MT, Shah J, Ward D, Thaman R, et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J. 2006;27:1933-41. (Pubitemid 44297366)
8. Seggewiss H, Rigopoulos A, Welge D, Ziemssen P, Faber L. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol. 2007;96:856-63. (Pubitemid 350164934)
9. Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy J Am Coll Cardiol. 2003;41:315-21. (Pubitemid 36092203)
10. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al. Long-term effects of surgical septal myec-tomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470-6. (Pubitemid 41040288)
11. Elliott PM, Gimeno B, Jr., Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;357:420-4. (Pubitemid 32156140)
12. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruc-tion on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295-303. (Pubitemid 36119984)
13. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, et al. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol. 2000; 36:2212-8.
14. Veselka J, Honek T Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hyper-trophic obstructive cardiomyopathy. Int J Cardiol. 2003;88: 27-32. (Pubitemid 36351406)
15. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hyper-trophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001;38: 1701-6. (Pubitemid 33065457)
16. Seggewiss H, Faber L, Ziemssen P, Gleichmann U. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy]. Dtsch Med Wochenschr. 2001;126:424-30. (Pubitemid 32328596)
17. Counihan PJ, Frenneaux MP, Webb DJ, McKenna WJ. Abnormal vascular responses to supine exercise in hyper-trophic cardiomyopathy. Circulation. 1991;84:686-96.
18. Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients. J Am Coll Cardiol. 2003;42:873-9. (Pubitemid 37059747)
19. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhyth-mias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;45:697-704. (Pubitemid 40278968)
20. Spirito P, Rapezzi C, Autore C, Bruzzi P, Bellone P, Ortolani P, et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation. 1994;90:2743-7.